These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34607108)

  • 1. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
    Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
    Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice.
    Li Y; Zheng G; Salimova E; Broughton BRS; Ricardo SD; de Veer M; Samuel CS
    Biomed Pharmacother; 2023 Feb; 158():114069. PubMed ID: 36502754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension.
    Li Y; Shen M; Ferens D; Broughton BRS; Murthi P; Saini S; Widdop RE; Ricardo SD; Pinar AA; Samuel CS
    Br J Pharmacol; 2021 Mar; 178(5):1164-1181. PubMed ID: 33450051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.
    Li Y; Ricardo SD; Samuel CS
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
    Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
    Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem-cells' exosomes are renoprotective in postmenopausal chronic kidney injury via reducing inflammation and degeneration.
    Alasmari WA; El-Shetry ES; Ibrahim D; ElSawy NA; Eldoumani H; Metwally AS; Saleh AA; Mona MM; Abd-Elsalam MM; Hendam BM; Essawi WM; Abourehab MAS; Abdelfattah-Hassan A
    Free Radic Biol Med; 2022 Mar; 182():150-159. PubMed ID: 35218913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice.
    Thomas JM; Ling YH; Huuskes B; Jelinic M; Sharma P; Saini N; Ferens DM; Diep H; Krishnan SM; Kemp-Harper BK; O'Connor PM; Latz E; Arumugam TV; Guzik TJ; Hickey MJ; Mansell A; Sobey CG; Vinh A; Drummond GR
    Hypertension; 2021 Nov; 78(5):1296-1309. PubMed ID: 34488433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B; Wang W; Ji XY; Ritter JK; Li N
    BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair.
    Liu X; Li X; Zhu W; Zhang Y; Hong Y; Liang X; Fan B; Zhao H; He H; Zhang F
    J Cell Physiol; 2020 Nov; 235(11):8010-8022. PubMed ID: 31960418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization.
    Zhao J; Li X; Hu J; Chen F; Qiao S; Sun X; Gao L; Xie J; Xu B
    Cardiovasc Res; 2019 Jun; 115(7):1205-1216. PubMed ID: 30753344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
    J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice.
    Tian M; Tang L; Wu Y; Beddhu S; Huang Y
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F558-F571. PubMed ID: 29873514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.
    Wang D; Luo Y; Myakala K; Orlicky DJ; Dobrinskikh E; Wang X; Levi M
    Sci Rep; 2017 Aug; 7(1):9793. PubMed ID: 28851937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from mesenchymal stem cells ameliorate renal fibrosis via delivery of miR-186-5p.
    Yang Y; Wang J; Zhang Y; Hu X; Li L; Chen P
    Hum Cell; 2022 Jan; 35(1):83-97. PubMed ID: 34585365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
    Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
    Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.
    Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD
    FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
    Rhaleb NE; Pokharel S; Sharma U; Carretero OA
    J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.